Clinical trial
Randomized Placebo-Controlled First-in-Human Study With GNbAC1
NCT01699555 is registered in ClinicalTrials.gov with GeNeuro Innovation SAS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Placebo-Controlled First-in-Human Study With GNbAC1
- Lead sponsor
- GeNeuro Innovation SAS
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- August 31, 2012
- Enrollment
- 33 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.